The first half of 2018 has yielded over 100 publications specifically addressing various aspects of ME/CFS. Reports encompass familiar domains such as neuroimaging, cytokine abnormalities and NK cell function, as well as explorations of novel technologies in biomarker identification and new findings of endocrine dysfunction, premature aging, post exertional inflammation and autoimmune activity. Here, we summarize highlights from many of the primary research articles published in the past 6 months
